Business Wire

Huawei Brings the All-Connected World to Mobile World Congress


Building on its success in delivering beautifully-designed and powerful high-end mobile devices, Huawei Consumer Business Group (CBG) today unveiled the HUAWEI MateBook X Pro, the HUAWEI MediaPad M5 Series and the HUAWEI 5G customer-premises equipment (CPE), the world’s first commercial terminal device supporting the globally recognized 3GPP telecommunications standard for 5G. With stunning new design updates and outstanding performance advances, Huawei’s new devices showcase the power of technology to deliver innovative computing experiences ready for the mobile world.

This press release features multimedia. View the full release here:

MateBook X Pro (Photo: Business Wire)

MateBook X Pro (Photo: Business Wire)

“At Huawei, we’re guided by a vision of an all-connected world, and to achieve that goal, we invest significantly in research and development to understand the ways in which people interact and connect with technology,” said Richard Yu, CEO of Huawei CBG. “We’ve made it our mission to push the boundaries of what technology and innovation are capable of. With the introduction of the new HUAWEI MateBook X Pro, HUAWEI MediaPad M5 Series and the world’s first 3GPP 5G CPE, we are delivering on the promise to provide breakthrough devices that redefine every part of the mobile computing experience.”

The HUAWEI MateBook X Pro and HUAWEI MediaPad M5 Series will be available in the spring of 2018 in China, Europe, North America, Asia Pacific and the Middle East.

  • HUAWEI MateBook X Pro

The HUAWEI MateBook X Pro is an ultra-slim, yet full-featured 13.9-inch notebook with an all-new 3K touch-enabled HUAWEI FullView Display and 91 percent screen-to-body ratio. Powered by an 8th Generation Intel® Core™ i7/i5 processor, a discrete NVIDIA® GeForce® MX150 GPU with 2GB GDDR5 and a long-lasting 57.4Wh (Typical Capacity) battery – making it one of the lightest and most powerful notebooks on the market.1 The HUAWEI MateBook X Pro features Dolby Atmos® Sound System and custom speakers that deliver breakthrough, immersive audio for sound to flow above and around you, making you feel like you’re inside the action.

  • HUAWEI MediaPad M5 Series

Ergonomically designed with a 2.5D glass screen and 2K HD, ClariVu 5.0-enhanced display, the sleek and powerful 8.4-inch and 10.8-inch tablets feature speakers tuned by Harman Kardon. HUAWEI Histen technology provides immersive 3D audio and fully supports Hi-Res audio for exceptional sound quality. The 10.8-inch HUAWEI MediaPad M5 Pro comes with an ultra-precise HUAWEI M-Pen featuring 4,096 levels of pressure sensitivity to make note-taking more realistic, easier and effortless.

  • 3GPP Standard 5G CPE

The HUAWEI 5G CPE is the first of its kind supporting the globally recognized 3GPP telecommunications standard for 5G. Available in indoor and outdoor configurations, it provides super-fast download speeds of up to 2Gbps and can operate on both 4G and 5G networks. The HUAWEI 5G CPE adopts Huawei’s internally developed Balong 5G01 chipset – the world’s first commercial chipset supporting the 3GPP standard, compatible with all 5G frequency bands, including sub-6GHz and millimeter wave (MMW).

Pricing and Availability 2

Device Specs Price
HUAWEI MateBook X Pro i5/8GB/256GB MW150 €1499
i5/8GB/512GB MX150 €1699
  i7/16GB/512GB MX150 €1899
HUAWEI MediaPad M5 8.4 inches 4GB+32GB WIFI €349
4GB+64GB WIFI €399
4GB+128GB WIFI €449
4GB+32GB LTE €399
4GB+64GB LTE €449
  4GB+128GB LTE €499
HUAWEI MediaPad M5 10.8 inches 4GB+32GB WIFI €399
4GB+64GB WIFI €449
4GB+128GB WIFI €499
4GB+32GB LTE €449
4GB+64GB LTE €499
  4GB+128GB LTE €549
HUAWEI MediaPad M5 Pro 10.8 inches 4GB+64GB WIFI €499
4GB+128GB WIFI €549
4GB+64GB LTE €549
  4GB+128GB LTE €599

About Huawei Consumer BG

Huawei’s products and services are available in more than 170 countries and are used by a third of the world’s population. Fifteen R&D centers have been set up in the United States, Germany, Sweden, Russia, India and China. Huawei Consumer BG is one of Huawei’s three business units and covers smartphones, PC and tablets, wearables and cloud services, etc. Huawei’s global network is built on almost 30 years of expertise in the telecom industry and is dedicated to delivering the latest technological advances to consumers around the world.

For regular updates on Huawei Consumer BG, follow us on:


1 Discrete graphics applied not to all configuration.
2 Sales tax included. Configurations and final price may vary in different countries

Contact information

Racepoint Global
Ben Haber, 617-624-3200

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 21:28Tiedote

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 19:05Tiedote

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 15:52Tiedote

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 15:50Tiedote

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 15:46Tiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 15:00Tiedote

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme